doi: 10.1097/QAD.0b013e328333bfa1.
Novel histone deacetylase inhibitors CG05 and CG06 effectively reactivate latently infected HIV-1
Affiliations
- PMID: 20154582
- DOI: 10.1097/QAD.0b013e328333bfa1
Item in Clipboard
Novel histone deacetylase inhibitors CG05 and CG06 effectively reactivate latently infected HIV-1
AIDS.
.
Abstract
Histone deacetylase plays an important role in HIV latency. Novel histone deacetylase inhibitors, CG05 and CG06, were evaluated for their roles in HIV latency using ACH2 cells. Both inhibitors were highly efficient in reactivation of provirus and exerted lesser toxicity compared with other known histone deacetylase inhibitors. Histone acetylation increased when proviruses were reactivated by the compounds. These new inhibitors may contribute to the reduction of the HIV reservoir when used in conjunction with highly active antiretroviral therapy.
Comment in
-
New inhibitors of HDAC to purge latent HIV-1 reservoir.Epigenomics. 2010 Aug;2(4):505-6. doi: 10.2217/epi.10.38. Epigenomics. 2010. PMID: 22121969 No abstract available.
Similar articles
-
Novel histone deacetylase inhibitor NCH-51 activates latent HIV-1 gene expression.FEBS Lett. 2011 Apr 6;585(7):1103-11. doi: 10.1016/j.febslet.2011.03.017. Epub 2011 Mar 12. FEBS Lett. 2011. PMID: 21402072
-
The novel histone deacetylase inhibitors metacept-1 and metacept-3 potently increase HIV-1 transcription in latently infected cells.AIDS. 2009 Sep 24;23(15):2047-50. doi: 10.1097/QAD.0b013e328330342c. AIDS. 2009. PMID: 19609198
-
HIV-1 reactivation induced by apicidin involves histone modification in latently infected cells.Curr HIV Res. 2011 Jun;9(4):202-8. doi: 10.2174/157016211796320333. Curr HIV Res. 2011. PMID: 21631428
-
Reactivation of latent HIV by histone deacetylase inhibitors.Trends Microbiol. 2013 Jun;21(6):277-85. doi: 10.1016/j.tim.2013.02.005. Epub 2013 Mar 18. Trends Microbiol. 2013. PMID: 23517573 Free PMC article. Review.
-
Chromatin-associated regulation of HIV-1 transcription: implications for the development of therapeutic strategies.Subcell Biochem. 2007;41:371-96. Subcell Biochem. 2007. PMID: 17484137 Review.
Cited by
-
Histone deacetylase inhibitors for purging HIV-1 from the latent reservoir.Mol Med. 2011 May-Jun;17(5-6):466-72. doi: 10.2119/molmed.2011.00076. Epub 2011 Mar 15. Mol Med. 2011. PMID: 21424110 Free PMC article. Review.
-
Altering cell death pathways as an approach to cure HIV infection.Cell Death Dis. 2013 Jul 11;4(7):e718. doi: 10.1038/cddis.2013.248. Cell Death Dis. 2013. PMID: 23846220 Free PMC article. Review.
-
HIV Integration Site Analysis of Cellular Models of HIV Latency with a Probe-Enriched Next-Generation Sequencing Assay.J Virol. 2016 Apr 14;90(9):4511-4519. doi: 10.1128/JVI.01617-15. Print 2016 May. J Virol. 2016. PMID: 26912621 Free PMC article.
-
Eliminating the latent HIV reservoir by reactivation strategies: advancing to clinical trials.Hum Vaccin Immunother. 2013 Apr;9(4):790-9. doi: 10.4161/hv.23202. Epub 2013 Apr 1. Hum Vaccin Immunother. 2013. PMID: 23563519 Free PMC article. Review.
-
HIV-1 transcription and latency: an update.Retrovirology. 2013 Jun 26;10:67. doi: 10.1186/1742-4690-10-67. Retrovirology. 2013. PMID: 23803414 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
